|
Market Closed -
Nasdaq
16:00:00 2026-10-23 EDT
|
5-day change | 1st Jan Change | ||
| 25.14 USD | -3.46% |
|
-2.82% | -6.12% |
| 08-18 | Barclays Adjusts Price Target on Amphastar Pharmaceuticals to $23 From $20, Maintains Equalweight Rating | MT |
| 08-07 | Amphastar Pharmaceuticals, Inc., Q2 2026 Earnings Call, Aug 06, 2026 |
Chart calendar Amphastar Pharmaceuticals, Inc.
Upcoming events on Amphastar Pharmaceuticals, Inc.
No events available
Past events on Amphastar Pharmaceuticals, Inc.
| 2026-08-06 | Earnings release - Q2 2026 | |
| 2026-08-06 | Earnings presentation | 17:00 |
| 2026-06-01 | Présentation aux Actionnaires / Analystes | 14:30 |
| 2026-06-01 | Annual General Meeting | 14:30 |
| 2026-05-07 | Earnings presentation | 17:00 |
| 2026-05-07 | Earnings release - Q1 2026 | |
| 2026-02-26 | Earnings release - Q4 2025 | |
| 2026-02-26 | Earnings presentation | 17:00 |
| 2025-11-06 | Earnings presentation | 17:00 |
| 2025-11-06 | Earnings release - Q3 2025 |
Annual results
| Fiscal Period | December | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 644 640 0.74% | 732 734 -0.32% | 720 727 -0.98% | 747 | 784 | 808 |
|
EBITDA Million USD | Released Forecast Spread | 284 263 7.86% | 311 303 2.83% | 248 262 -5.38% | 213 | 212 | 208 |
|
EBIT Million USD | Released Forecast Spread | 246 234 5.01% | 258 261 -1.16% | 216 218 -0.97% | 180 | 184 | 193 |
|
Earnings before Tax (EBT) | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 |
|
Net income Million USD | Released Forecast Spread | 138 170 -19.3% | 160 173 -7.78% | 98,1 156 -37.25% | 99,3 | 115 | 111 |
|
EPS USD | Released Forecast Spread | 2,60 3,20 -18.75% | 3,06 3,30 -7.41% | 2,03 3,13 -35.16% | 2,17 | 2,64 | 2,48 |
| Announcement Date | 28/02/24 | 27/02/25 | 26/02/26 | - |
Quarterly results
| Fiscal Period | June | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 | 2027 Q1 | 2027 Q2 | 2027 Q3 | 2027 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 187 189 -1.19% | 171 173 -1.46% | 174 173 0.67% | 192 185 3.63% | 183 190 -3.7% | 171 173 -1.28% | 184 180 2.21% | 198 | 195 | 186 | 196 | 205 | 201 |
|
EBITDA Million USD | Released Forecast Spread | 70,4 78,6 -10.5% | 66,7 52,9 26.12% | 63,2 53,5 18.02% | 75,2 59,9 25.4% | 56,2 69,0 -18.66% | 38,3 77,5 -50.63% | 67,4 61,6 9.49% | 62,0 | 55,0 | ||||
|
EBIT Million USD | Released Forecast Spread | 57,0 63,8 -10.67% | 51,9 47,1 10.27% | 54,8 49,7 10.42% | 61,0 54,0 13.08% | 48,1 57,7 -16.69% | 30,2 43,8 -31.13% | 53,1 41,1 29.09% | 51,6 | 45,3 | 37,9 | 45,6 | 50,2 | 42,3 |
|
Net income Million USD | Released Forecast Spread | 38,0 36,5 3.91% | 25,3 28,3 -10.61% | 31,0 31,0 0.1% | 17,4 31,0 -44.03% | 24,4 30,0 -18.57% | 6,42 27,0 -76.22% | 30,3 17,0 78.52% | 30,0 | 32,0 | 30,0 | 31,0 | 33,0 | 30,0 |
|
EPS USD | Released Forecast Spread | 0,74 0,78 -5.11% | 0,51 0,56 -8.72% | 0,64 0,62 2.44% | 0,37 0,73 -49.38% | 0,51 0,82 -37.55% | 0,14 0,57 -75.44% | 0,67 0,37 81.08% | 0,67 | 0,69 | 0,64 | 0,65 | 0,71 | 0,64 |
| Announcement Date | 27/02/25 | 07/05/25 | 07/08/25 | 06/11/25 | 26/02/26 | 07/05/26 | 06/08/26 | - | - | - | - | - | - |
| 2026-10-25 | Board of Directors Meeting | ||
| 2026-10-25 | Board of Directors Meeting | ||
| 2026-10-25 | Earnings release - Q2 2027 | ||
| 2026-10-26 | Board of Directors Meeting | ||
| 2026-10-26 | Information meeting | 10:00 | |
| 2026-10-26 | Earnings release - Q2 2027 | ||
| 2026-10-26 | Earnings presentation | 08:30 | |
| 2026-10-26 | Board of Directors Meeting | ||
| 2026-10-26 | Earnings presentation | 03:00 | |
| 2026-10-26 | Board of Directors Meeting |
Past sector events for Amphastar Pharmaceuticals, Inc.
| Today | Earnings release - Q3 2026 | ||
| Today | Earnings release - Q3 2026 | ||
| Today | Earnings release - Q3 2026 | ||
| Today | Earnings release - Q3 2026 | ||
| Today | Earnings release - Q3 2026 | ||
| Today | Earnings release - Q3 2026 | ||
| Today | Earnings release - Q3 2026 | ||
| Today | Earnings release - Q3 2026 | ||
| Today | Earnings release - Q3 2026 | ||
| Today | Earnings release - Q3 2026 |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Stocks
- AMPH Stock
- Calendar Amphastar Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
















